beta
Trial Radar AI
Clinical Trial NCT06423924 for Colorectal Cancer, Second Primary Cancer is not yet recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here.
One study matched filter criteria
Card View
Back to Search

Second Primary Cancer and Early-onset Colorectal Cancer 10,000

Not yet recruiting
Clinical Trial NCT06423924 is an observational study for Colorectal Cancer, Second Primary Cancer and is currently not yet recruiting. Enrollment is planned to begin on 11 May 2024 and continue until the study accrues 10,000 participants. Led by LI XIN-XIANG, this study is expected to complete by 1 June 2024. The latest data from ClinicalTrials.gov was last updated on 21 May 2024.
Brief Summary
The objective of this study was to analyze the pathological factors influencing the occurrence and prognosis of SPC in CRC patients of varying ages and compare the differences in the patterns of SPC occurrence and prognosis among patients of different age groups.
Official Title

Risk Factors, Cancer Types and Prognostic Significance of Second Primary Cancer Based on the Early-onset and Late-onset Colorectal Cancer

Conditions
Colorectal CancerSecond Primary Cancer
Other Study IDs
  • CRCSPM
NCT ID Number
NCT06423924
Start Date (Actual)
2024-05-11
Last Update Posted
2024-05-21
Completion Date (Estimated)
2024-06-01
Enrollment (Estimated)
10,000
Study Type
Observational
Status
Not yet recruiting
Arms / Interventions
Participant Group/ArmIntervention/Treatment
<50 years
no intervention
no intervention
50-69 years
no intervention
no intervention
≥70 years
no intervention
no intervention
Primary Outcome Measures
Outcome MeasureMeasure DescriptionTime Frame
overall survival
The duration from the date of surgery to death for any reason or the last recorded follow-up, whichever comes first. Up to 100 months
The duration from the date of surgery to death for any reason or the last recorded follow-up, whichever comes first. Up to 100 months
Participation Assistant
Eligibility Criteria

Eligible Ages
Adult, Older Adult
Minimum Age
18 Years
Eligible Sexes
All
  • Patients undergoing radical surgery for colorectal cancer at Fudan University Shanghai Cancer Center between January 2008 and December 2018.
  • Stage Ⅰ-Ⅳ colorectal cancer confirmed by clear pathological information

  • Previous history of other cancers before surgery
  • Patients under 18 years old or over 80 years old
LI XIN-XIANG logoLI XIN-XIANG
Study Responsible Party
LI XIN-XIANG, Sponsor-Investigator, professor, Fudan University
No contact data.